News

Search for Articles

Feb 27, 2023

Puzzle Medical Closes CAN$ 34 million Series A Funding Round to Complete Human Feasibility Study Led by Cordis-X

Read More

Feb 23, 2023

2022 Broadview Ventures Annual Report

Read More

Feb 16, 2023

HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards

Read More

Feb 9, 2023

Basking Biosciences Presents Positive Clinical Results from Safety and Dose-Escalation Study for First Reversible Thrombolytic Agent at ISC 2023

Read More

Jan 31, 2023

Basking Biosciences to Present Clinical Trial Results on First Reversible Thrombolytic Agent at American Heart Association International Stroke Conference 2023

Read More

Jan 26, 2023

Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial

Read More